Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma
The clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreat...
Saved in:
| Main Authors: | , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Hematology |
| Online Access: | http://dx.doi.org/10.1155/2016/6745286 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832567050054139904 |
|---|---|
| author | Claudio Cerchione Davide Nappi Maria Di Perna Irene Zacheo Anna Emanuele Pareto Marco Picardi Lucio Catalano Fabrizio Pane |
| author_facet | Claudio Cerchione Davide Nappi Maria Di Perna Irene Zacheo Anna Emanuele Pareto Marco Picardi Lucio Catalano Fabrizio Pane |
| author_sort | Claudio Cerchione |
| collection | DOAJ |
| description | The clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreatment with previously adopted and effective therapy, although unpredictable, could be an effective option. In this report, we describe the clinical history of a patient, previously treated with 9 lines of therapy, refractory to bortezomib and IMIDs, for whom the retreatment with bendamustine resulted in a stable disease with good quality of life. |
| format | Article |
| id | doaj-art-ab51cd43838f4f29842bdcf98d34712e |
| institution | Kabale University |
| issn | 2090-6560 2090-6579 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Hematology |
| spelling | doaj-art-ab51cd43838f4f29842bdcf98d34712e2025-02-03T01:02:30ZengWileyCase Reports in Hematology2090-65602090-65792016-01-01201610.1155/2016/67452866745286Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple MyelomaClaudio Cerchione0Davide Nappi1Maria Di Perna2Irene Zacheo3Anna Emanuele Pareto4Marco Picardi5Lucio Catalano6Fabrizio Pane7Hematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyHematology, University Federico II, Via Pansini 5, 80131 Napoli, ItalyThe clinical management of relapsed/refractory multiple myeloma and the correct choice of the most suitable therapy in heavily pretreated and fragile patients are tough clinical issues for clinicians. In advanced phases of disease, the choice of available therapies becomes very poor, and the retreatment with previously adopted and effective therapy, although unpredictable, could be an effective option. In this report, we describe the clinical history of a patient, previously treated with 9 lines of therapy, refractory to bortezomib and IMIDs, for whom the retreatment with bendamustine resulted in a stable disease with good quality of life.http://dx.doi.org/10.1155/2016/6745286 |
| spellingShingle | Claudio Cerchione Davide Nappi Maria Di Perna Irene Zacheo Anna Emanuele Pareto Marco Picardi Lucio Catalano Fabrizio Pane Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma Case Reports in Hematology |
| title | Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma |
| title_full | Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma |
| title_fullStr | Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma |
| title_full_unstemmed | Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma |
| title_short | Retreatment with Bendamustine-Bortezomib-Dexamethasone in a Patient with Relapsed/Refractory Multiple Myeloma |
| title_sort | retreatment with bendamustine bortezomib dexamethasone in a patient with relapsed refractory multiple myeloma |
| url | http://dx.doi.org/10.1155/2016/6745286 |
| work_keys_str_mv | AT claudiocerchione retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT davidenappi retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT mariadiperna retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT irenezacheo retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT annaemanuelepareto retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT marcopicardi retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT luciocatalano retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma AT fabriziopane retreatmentwithbendamustinebortezomibdexamethasoneinapatientwithrelapsedrefractorymultiplemyeloma |